Spring til hovednavigation Spring til søgning Spring til hovedindhold

RNA sequencing unravels novel L cell constituents and mechanisms of GLP-1 secretion in human gastric bypass-operated intestine

  • Michael G. Miskelly
  • , Andreas Lindqvist
  • , Elena Piccinin
  • , Alexander Hamilton
  • , Elaine Cowan
  • , Bent Johnny Nergård
  • , Rita Del Giudice
  • , Mtakai Ngara
  • , Luis R. Cataldo
  • , Dmytro Kryvokhyzha
  • , Petr Volkov
  • , Luke Engelking
  • , Isabella Artner
  • , Jens O. Lagerstedt
  • , Lena Eliasson
  • , Emma Ahlqvist
  • , Antonio Moschetta
  • , Jan Hedenbro
  • , Nils Wierup*
  • *Corresponding author af dette arbejde

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

93 Downloads (Pure)

Abstract

Aims/hypothesis: Roux-en-Y gastric bypass surgery (RYGB) frequently results in remission of type 2 diabetes as well as exaggerated secretion of glucagon-like peptide-1 (GLP-1). Here, we assessed RYGB-induced transcriptomic alterations in the small intestine and investigated how they were related to the regulation of GLP-1 production and secretion in vitro and in vivo. Methods: Human jejunal samples taken perisurgically and 1 year post RYGB (n=13) were analysed by RNA-seq. Guided by bioinformatics analysis we targeted four genes involved in cholesterol biosynthesis, which we confirmed to be expressed in human L cells, for potential involvement in GLP-1 regulation using siRNAs in GLUTag and STC-1 cells. Gene expression analyses, GLP-1 secretion measurements, intracellular calcium imaging and RNA-seq were performed in vitro. OGTTs were performed in C57BL/6j and iScd1 −/− mice and immunohistochemistry and gene expression analyses were performed ex vivo. Results: Gene Ontology (GO) analysis identified cholesterol biosynthesis as being most affected by RYGB. Silencing or chemical inhibition of stearoyl-CoA desaturase 1 (SCD1), a key enzyme in the synthesis of monounsaturated fatty acids, was found to reduce Gcg expression and secretion of GLP-1 by GLUTag and STC-1 cells. Scd1 knockdown also reduced intracellular Ca2+ signalling and membrane depolarisation. Furthermore, Scd1 mRNA expression was found to be regulated by NEFAs but not glucose. RNA-seq of SCD1 inhibitor-treated GLUTag cells identified altered expression of genes implicated in ATP generation and glycolysis. Finally, gene expression and immunohistochemical analysis of the jejunum of the intestine-specific Scd1 knockout mouse model, iScd1 −/−, revealed a twofold higher L cell density and a twofold increase in Gcg mRNA expression. Conclusions/interpretation: RYGB caused robust alterations in the jejunal transcriptome, with genes involved in cholesterol biosynthesis being most affected. Our data highlight SCD as an RYGB-regulated L cell constituent that regulates the production and secretion of GLP-1.
OriginalsprogEngelsk
TidsskriftDiabetologia
Vol/bind67
Udgave nummer2
Sider (fra-til)356-370
ISSN0012-186X
DOI
StatusUdgivet - 2023

Bibliografisk note

Funding Information:
Open access funding provided by Lund University. NW is supported by the Swedish Research Council (2020-01017, 2017-00862 and 521-2012-2119), regional research foundation Avtal om Läkarutbildning och Forskning (ALF), Diabetes Wellness Research Foundation Sweden, Albert Påhlsson Foundation, Royal Physiographic Society in Lund and Swedish Diabetes Foundation. Lund University Diabetes Centre is supported by the Swedish Research Council, Linnaeus grant (Dnr 349-2006-237), Strategic Research Area Exodiab (Dnr 2009-1039) and the Swedish Foundation for Strategic Research (Dnr IRC15-0067). JOL is supported by the Swedish Research Council (2020-02179).

Publisher Copyright:
© 2023, The Author(s).

Finansiering

Open access funding provided by Lund University. NW is supported by the Swedish Research Council (2020-01017, 2017-00862 and 521-2012-2119), regional research foundation Avtal om Läkarutbildning och Forskning (ALF), Diabetes Wellness Research Foundation Sweden, Albert Påhlsson Foundation, Royal Physiographic Society in Lund and Swedish Diabetes Foundation. Lund University Diabetes Centre is supported by the Swedish Research Council, Linnaeus grant (Dnr 349-2006-237), Strategic Research Area Exodiab (Dnr 2009-1039) and the Swedish Foundation for Strategic Research (Dnr IRC15-0067). JOL is supported by the Swedish Research Council (2020-02179).

Citationsformater